|Bid||0.00 x 21500|
|Ask||0.00 x 1300|
|Day's Range||27.02 - 27.23|
|52 Week Range||21.48 - 30.59|
|PE Ratio (TTM)||211.01|
|Forward Dividend & Yield||1.48 (5.59%)|
|1y Target Est||N/A|
With similar portfolios but very different dividend yields, you might be tempted to go with Senior Housing Property Trust. Read this first.
HCP (HCP) delivered FFO per share and revenue surprises of 2.17% and 0.50%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
HCP Q2 results likely to reflect benefit from shedding of Brookdale assets. However, rising interest rates remains a concern.
The pieces have begun to come together for South San Francisco’s biotech space puzzle. Here’s the latest info on who’s doing what where.
Alexandria Real Estate Equities (ARE) Q2 results will likely reflect the benefits from robust operating environment in the U.S office space. Nonetheless, non-core dispositions remain a drag.
Vornado's (VNO) Q2 results are expected to reflect gains from strong fundamentals in the U.S office space. Further, its New York office portfolio performance will likely display decent figures.
These two healthcare industry players have similarities as well as differences -- yet the growth opportunities are notable for both
HCP has been selling several of its seniors housing assets in a bid to improve the quality of the company's portfolio, strengthen balance sheet and lower the Brookdale operator concentration.
Apollo Global Management LLC is the mystery buyer that’s under contract to purchase a $428 million portfolio from HCP Inc., according to a person with knowledge of the matter. The New York firm is buying 22 properties managed by Brookdale Senior Living Inc., said the person, who asked not to be identified because the matter is confidential. HCP said on June 5 that it was under contract to sell the portfolio, which comprises for 2,781 units, to a third party without revealing its identity.
HCP's constant efforts to lower Brookdale concentration in its portfolio are aiding the company. However, the dilutive impact on earnings from the sale of assets is unavoidable.
HCP's concerted efforts expected to improve portfolio quality, enhance operator diversification and strengthen balance sheet.
Health care real estate investment trusts have underperformed the broader REIT sector year-to-date. While Raymond James continuesto have an Underweight sector recommendation, the firm recommends select ...
Five years after the company started and two years after it moved into the new biotech lab-office project at Highway 101 and Oyster Point Boulevard, this company with experimental drugs in Alzheimer's, Parkinson's and ALS will quadruple its space.